Your browser doesn't support javascript.
loading
Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain.
Ricart, W; López, J; Mozas, J; Pericot, A; Sancho, M A; González, N; Balsells, M; Luna, R; Cortázar, A; Navarro, P; Ramírez, O; Flández, B; Pallardo, L F; Hernández, A; Ampudia, J; Fernández-Real, J M; Corcoy, R.
  • Ricart W; Unit of Diabetes, Endocrinology and Nutrition, Hospital Universitari de Girona Doctor Josep Trueta, Avgda. de França s.n., 17007, Girona, Spain. uden.wricart@htrueta.scs.es
Diabetologia ; 48(6): 1135-41, 2005 Jun.
Article en En | MEDLINE | ID: mdl-15889233
AIMS/HYPOTHESIS: This study was carried out to determine the impact of American Diabetes Association (ADA) 2000 criteria for the diagnosis of gestational diabetes mellitus (GDM) in the Spanish population. METHODS: Pregnant women were assigned to one of four categories: negative screenees, false-positive screenees, ADA-only-GDM (untreated) and GDM according to National Diabetes Data Group (NDDG) criteria (treated). Fetal macrosomia and Caesarean section were defined as primary outcomes, with seven additional secondary outcomes. RESULTS: Of 9,270 pregnant women screened for GDM, 819 (8.8%) met NDDG criteria. If the threshold for defining GDM had been lowered to ADA criteria, an additional 2.8% of women would have been defined as having the condition (relative increase of 31.8%). Maternal characteristics of women with ADA-only-GDM were between those of false-positive screenees and women with NDDG-GDM. The risk of diabetes-associated complications was slightly elevated in the individuals who would have been classified as abnormal only after the adoption of ADA criteria. In addition, the ADA-only-GDM contribution to morbidity was lower than that of other variables, especially BMI. CONCLUSIONS/INTERPRETATION: Use of the ADA criteria to identify GDM would result in a 31.8% increase in prevalence compared with NDDG criteria. However, as the contribution of these additionally diagnosed cases to adverse GDM outcomes is not substantial, a change in diagnostic criteria is not warranted in our setting.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Sociedades Médicas / Diabetes Gestacional Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged / Newborn / Pregnancy País como asunto: America do norte / Europa Idioma: En Año: 2005 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Sociedades Médicas / Diabetes Gestacional Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged / Newborn / Pregnancy País como asunto: America do norte / Europa Idioma: En Año: 2005 Tipo del documento: Article